Phase 2 trial of Proton Beam Therapy for malignancy pediatric tumor.

Phase 2 trial of Proton Beam Therapy for malignancy pediatric tumor. - PBT for malignancy pediatric tumor.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026419

Enrollment

2000

Registered

2017-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant pediatric tumor below the age of 20.

Interventions

Proton beam therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: In pregnancy.

Design outcomes

Primary

Measure	Time frame
Late toxicity, acute toxicity, secondary cancer	—

Secondary

Measure	Time frame
Overall survival, Progression free survival, Local control rate	—

Countries

Japan

Contacts

Public ContactMasashi Mizumoto

University of Tsukuba Hospital Radiation Oncology

proton_therapy@pmrc.tsukuba.ac.jp029-853-7100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026